Menu

Dozens of Researchers Exposed to Anthrax

As many as 75 scientists at the US Centers for Disease Control and Prevention may have come in contact with live Bacillus anthracis, the bacteria that cause anthrax.

Jun 22, 2014
Bob Grant

Color-enhanced scanning electron micrograph shows rod-shaped Bacillus anthracis (yellow) and a red blood cell (red) in a monkey’s spleen.NIAID, ARTHUR FRIEDLANDERApproximately 75 researchers working at the US Centers for Disease Control and Prevention (CDC) in Atlanta may have been exposed to live anthrax bacteria when the microbes were sent to laboratories that were not equipped to safely handle the pathogen, the federal agency announced Thursday (June 19).

CDC scientists were studying the bacteria in a high-level biosecurity lab and then transferred the samples to three lower-security labs without first properly inactivating the live microbes. Workers in those labs handled the samples without using personal protective equipment, such as gloves. The procedural lapse happened between June 6 and June 13, and CDC spokesperson Thomas Skinner told The New York Times that while none of the researchers exposed to the bacteria are showing symptoms of infection, many of them are receiving prophylactic antibiotic treatment “out of an abundance of caution.”

CNN reported on Thursday afternoon that 54 CDC employees determined to have been in the labs or hallways at the time live anthrax was present have been seen by the agency’s Occupational Health Clinic. Of those, only two people chose not to take oral antibiotics. An additional 27 staffers have been given the anthrax vaccine. Other exposed individuals were scheduled to be seen by doctors on Friday.

Paul Meechan, director of the environmental health and safety compliance office at the CDC, told The Guardian that the agency discovered the exposure on the evening of June 13 and is conducting an internal investigation to determine how the lapse occurred. “This should not have happened,” he said. “We’re taking care of it. We will not let our people be at risk.”

“We will report findings of this review and all steps we take to improve lab-safety processes as a result of this incident,” the CDC’s statement read.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.